Statin Intolerance in Patients With Myocardial Infarction
Overview
Patients with acute coronary syndrome (MI, NSTEMI, USAP) will be included. They will be screened for statin intolernace for 6 months.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: March 2, 2020
Interventions
- Diagnostic Test: Statin intolerance test
- Statin intolerance test
Clinical Trial Outcome Measures
Primary Measures
- Statin intolerance
- Time Frame: 6 months
- Number (percentage) of patients with statin intolerance
Participating in This Clinical Trial
Inclusion Criteria
- Acute coronary syndrome Exclusion Criteria:
- Being on statin, having statin related side effects
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Investigator Details
- Lead Sponsor
- Turkish Society of Cardiology
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.